ROLE OF CD44 IN THE INVASIVENESS OF GLIOBLASTOMA-MULTIFORME AND THE NONINVASIVENESS OF MENINGIOMA - AN IMMUNOHISTOCHEMISTRY STUDY

被引:51
|
作者
ARIZA, A
LOPEZ, D
MATE, JL
ISAMAT, M
MUSULEN, E
PUJOL, M
LEY, A
NAVASPALACIOS, JJ
机构
[1] HOSP UNIV GERMANS TRIAS & PUJOL,DEPT NEUROSURG,E-08916 BADALONA,SPAIN
[2] UNIV AUTONOMA BARCELONA,HOSP SANTA CREU & SANT PAU,DEPT PATHOL,BARCELONA,SPAIN
[3] HOSP ESPERIT SANT,DEPT PATHOL,BARCELONA,SPAIN
[4] FDN ECHEVARNE,BARCELONA,SPAIN
关键词
CD44; MENINGIOMA; GLIOBLASTOMA MULTIFORME; INVASION; METASTASIS; IMMUNOHISTOCHEMISTRY;
D O I
10.1016/0046-8177(95)90278-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD44 is a polymorphic family of cell adhesion molecules that seems to be instrumental in the mechanism of tumor invasion and metastasis. Tumor cell expression of CD44, or lack thereof, may be one of the factors conditioning the highly disparate ability to penetrate the brain extracellular matrix (ECM) exhibited by glioblastoma multiforme (GM) and conventional meningioma. To assess the presence of CD44 in these two tumor types we have immunohistochemically investigated the expression of CD44 standard form (CD44s) and the variant isoforms containing the domain encoded by variant exon 3 (CD44v3) and variant exon 6 (CD44v6) in paraffin-embedded tissue from 10 conventional meningiomas and 10 GMs. A CD44s-/CD44v-phenotype was discerned in the meningioma cases, whereas GMs featured a CD44s+/CD44v- expression profile. Consequently, the growth patterns of meningioma and GM seem to be, at least in part, a reflection of their CD44 expression status. Paucity of CD44 in meningioma cells would render them unable to infiltrate the brain ECM, whereas CD44-rich glioma cells would successfully migrate through it. Conversely, lack of CD44v expression would contribute to explain the lack of metastatic potential characterizing both conventional meningioma and GM. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:1144 / 1147
页数:4
相关论文
共 50 条
  • [1] The role of CD44 in glioblastoma multiforme
    Mooney, Kelly L.
    Choy, Winward
    Sidhu, Sabrin
    Pelargos, Panayiotis
    Bui, Timothy T.
    Voth, Brittany
    Barnette, Natalie
    Yang, Isaac
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 34 : 1 - 5
  • [2] Evaluation of the Prognostic Value of CD44 in Glioblastoma Multiforme
    Wei, Kuo-Chen
    Huang, Chiung-Yin
    Chen, Pin-Yuan
    Feng, Li-Ying
    Wu, Tai-Wei Erich
    Chen, Shu-Mei
    Tsai, Hong-Chieh
    Lu, Yu-Jen
    Tsang, Ngan-Ming
    Tseng, Chen-Kan
    Pai, Ping-Ching
    Shin, Jyh-Wei
    ANTICANCER RESEARCH, 2010, 30 (01) : 253 - 259
  • [3] REPORT OF A CASE OF CONGENITAL GLIOBLASTOMA-MULTIFORME - AN IMMUNOHISTOCHEMICAL STUDY
    MAZZONE, D
    MAGRO, G
    LUCENTI, A
    GRASSO, S
    CHILDS NERVOUS SYSTEM, 1995, 11 (05) : 311 - 313
  • [4] Differential expression of CD44 variants among meningioma subtypes
    Suzuki, SO
    Iwaki, T
    Kitamoto, T
    Mizoguchi, M
    Fukui, M
    Tateishi, J
    JOURNAL OF CLINICAL PATHOLOGY-CLINICAL MOLECULAR PATHOLOGY EDITION, 1996, 49 (03): : M140 - M146
  • [5] ACCELERATED RADIOTHERAPY IN GLIOBLASTOMA-MULTIFORME - A DOSE SEARCHING PROSPECTIVE-STUDY
    GONZALEZ, DG
    MENTEN, J
    BOSCH, DA
    VANDERSCHUEREN, E
    TROOST, D
    HULSHOF, MCCM
    BERNIER, J
    RADIOTHERAPY AND ONCOLOGY, 1994, 32 (02) : 98 - 105
  • [6] A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence
    Inoue, Akihiro
    Ohnishi, Takanori
    Nishikawa, Masahiro
    Ohtsuka, Yoshihiro
    Kusakabe, Kosuke
    Yano, Hajime
    Tanaka, Junya
    Kunieda, Takeharu
    CANCERS, 2023, 15 (19)
  • [7] GLIOBLASTOMA-MULTIFORME IN 4 SIBLINGS - A CYTOGENETIC AND MOLECULAR-GENETIC STUDY
    DIRVEN, CMF
    TUERLINGS, J
    MOLENAAR, WM
    GO, KG
    LOUIS, DN
    JOURNAL OF NEURO-ONCOLOGY, 1995, 24 (03) : 251 - 258
  • [8] PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
    Mihic, Josip
    Rotim, Kresimir
    Vucic, Majda
    Dragicevic, Ida Hude
    Boric, Marta
    Lugovic-Mihic, Liborija
    ACTA CLINICA CROATICA, 2019, 58 (03) : 455 - 462
  • [9] A DOSE-ESCALATION STUDY OF TAMOXIFEN THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA-MULTIFORME
    VERTOSICK, FT
    SELKER, RG
    ARENA, V
    JOURNAL OF NEUROSURGERY, 1994, 80 (02) : A385 - A385
  • [10] CD44, THE HYALURONATE RECEPTOR - A ROLE IN CANCER INVASIVE AND METASTATIC PROPERTIES
    THOMAS, L
    BULLETIN DU CANCER, 1993, 80 (10) : 833 - 844